Insider trading

Period: 120 months Stock: AUPH + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

103 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

103 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

103 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

103 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
103 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
103 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

103 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2023
Bought
$178.28K 20,000 at 8.91
40.0%
Largest buy in 3 yrs
2 Mar 2023
Robertson Stephen P. EVP, General Counsel
Sold, plan not stated
$173.45K 19,402 at 8.94
6.0%
2 Mar 2023
Miller Joseph M Chief Financial Officer
Sold, plan not stated
$100.99K 11,296 at 8.94
3.3%
21 Nov 2022
Donley Matthew Maxwell Ex VP, Internal Operations
Bought
$46.60K 10,000 at 4.66
55.8%
+56% of stake
9 Nov 2022
Habig Scott Michael Chief Commercial Officer
Bought
$25.08K 5,000 at 5.02
opened
First buy on file
7 Nov 2022
Martin Michael Robert Chief Business Officer
Bought
$154.80K 30,000 at 5.16
50.4%
First buy on file
9 Mar 2022
Bought
$54.99K 5,000 at 11.00
83.3%
Largest buy in 3 yrs
4 Mar 2022
Bought
$54.10K 5,000 at 10.82
11.1%
2 Mar 2022
Greenleaf Peter Chief Executive Officer
Sold, plan not stated
$108.91K 9,068 at 12.01
21.6%
2 Mar 2022
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$58.24K 4,849 at 12.01
7.5%
2 Mar 2022
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$58.24K 4,849 at 12.01
6.5%
2 Mar 2022
Solomons Neil Chief Medical Officer
Sold, plan not stated
$58.20K 4,846 at 12.01
5.1%
2 Mar 2022
Colao Massimilano Chief Commercial Officer
Sold, plan not stated
$38.49K 3,205 at 12.01
19.2%
2 Mar 2022
Miller Joseph M Chief Financial Officer
Sold, plan not stated
$36.75K 3,060 at 12.01
31.6%
2 Mar 2022
Donley Matthew Maxwell Ex VP, Intern'l Operations
Sold, plan not stated
$36.65K 3,052 at 12.01
15.8%
3 Jan 2022
Hagan Joseph P Director
Sold, plan not stated 2×
$903.65K 40,000 at 22.59
92.0%
Sold half or more
13 Dec 2021
Leversage Jill Director
Bought
$32.06K 1,600 at 20.04
43.2%
Largest buy in 3 yrs
11 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$2.89M 100,000 at 28.89
53.4%
Sold half or more
11 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$1.16M 40,000 at 29.01
41.7%
10 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated 2×
$3.11M 100,000 at 31.11
53.4%
Sold half or more
10 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$1.87M 60,000 at 31.14
47.3%
9 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$1.51M 50,000 at 30.17
28.3%
9 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$1.51M 50,000 at 30.17
36.4%
1 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$1.42M 45,000 at 31.64
24.7%
1 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$1.42M 45,000 at 31.64
20.3%
25 Oct 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$3.87M 130,000 at 29.75
66.4%
Sold half or more
21 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$2.10M 87,500 at 24.02
33.1%
21 Sep 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated 2×
$779.53K 32,500 at 23.99
24.4%
20 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$616.98K 28,500 at 21.65
13.9%
14 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 3×
$2.87M 134,000 at 21.38
43.1%
14 Sep 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$489.38K 22,500 at 21.75
17.5%
10 Sep 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$2.98M 150,000 at 19.84
52.2%
Sold half or more
10 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$495.00K 25,000 at 19.80
12.4%
10 Sep 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated 2×
$197.95K 10,000 at 19.80
7.2%
7 Sep 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$135.75K 7,500 at 18.10
4.1%
7 Sep 2021
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$91.50K 5,000 at 18.30
3.5%
26 Aug 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$400.73K 22,500 at 17.81
10.9%
25 Aug 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$79.25K 5,000 at 15.85
3.5%
9 Aug 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$721.35K 45,000 at 16.03
24.0%
9 Aug 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$80.05K 5,000 at 16.01
2.4%
28 Jul 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$69.30K 5,000 at 13.86
2.3%
22 Jun 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$68.80K 5,000 at 13.76
2.3%
12 May 2021
Bought 2×
$33.80K 3,000 at 11.27
100%
Largest buy in 3 yrs
11 May 2021
Donley Matthew Maxwell Ex VP, Intern'l Operations
Bought
$99.74K 9,900 at 10.07
opened
First buy on file
11 May 2021
Greenleaf Peter Chief Executive Officer
Bought 2×
$54.89K 5,125 at 10.71
61.5%
First buy on file
11 May 2021
Leversage Jill Director
Bought
$27.39K 2,500 at 10.96
208%
Largest buy in 3 yrs
11 May 2021
Bought 2×
$16.73K 1,500 at 11.15
100%
First buy on file
11 May 2021
Miller Joseph M Chief Financial Officer
Bought
$9.74K 1,000 at 9.74
opened
First buy on file
12 Mar 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$539.60K 40,000 at 13.49
17.6%
5 Mar 2021
Bought
$65.00K 5,000 at 13.00
12.5%
First buy on file
Showing 51–100 of 103. ← Newer Page 2 of 3 Older →